Parent Telehealth Intervention for Children With Autism

January 4, 2022 updated by: Megan Roberts, Northwestern University

Parent Language Intervention for Autism

As a result of the COVID-19 pandemic, telecoaching/telepractice models are of urgent importance. Given this, parents in the study will receive parent coaching through weekly video calls. To help us understand the best types of telecoaching, we will offer all participants responsive coaching, with half of the participants receiving an additional opportunity to reflect on their own use of language strategies with a therapist using video feedback and the other half receiving responsive coaching as usual, without video feedback. This information is important in helping us to understand the best way to coach parents using a telepractice model so that parents implement the intervention at high fidelity. Furthermore, we will aim to understand how parent learning style may also influence the implementation of these strategies.

Study Overview

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Evanston, Illinois, United States, 60208
        • Northwestern University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 4 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Child inclusion criteria include:

  • diagnosis of ASD or showing signs of ASD based on autism screening
  • chronological age of less than 48 months
  • a parent who is willing to learn intervention strategies
  • English as the primary language spoken in the home

Parent inclusion criteria include:

- Biological Mother

Exclusion Criteria:

  • Children or parents with additional impairments (e.g., blindness, deafness, genetic syndromes) will be excluded from the study.
  • Fathers or caregivers other than the child's Mother will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Parent Learning Style 1
Mothers with Learning Style 1 will be randomly assigned to receive the responsive intervention with video feedback or without video feedback.
Parents will receive responsive training, but will not watch themselves on video to reflect on their strategy use.
Other Names:
  • No Video Feedback
EXPERIMENTAL: Parent Learning Style 2
Mothers with Learning Style 2 will be randomly assigned to receive the responsive intervention with video feedback or without video feedback.
Parents will receive responsive training and watch themselves on video to reflect on their strategy use.
Other Names:
  • Video Feedback
ACTIVE_COMPARATOR: Learning Style 1 (Parent)
Mothers with Learning Style 1 will be randomly assigned to receive the responsive intervention with video feedback or without video feedback.
Parents will receive responsive training and watch themselves on video to reflect on their strategy use.
Other Names:
  • Video Feedback
ACTIVE_COMPARATOR: Learning Style 2 (Parent)
Mothers with Learning Style 2 will be randomly assigned to receive the responsive intervention with video feedback or without video feedback.
Parents will receive responsive training, but will not watch themselves on video to reflect on their strategy use.
Other Names:
  • No Video Feedback

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parent Use of Language Support Strategies (Mother-child interaction)
Time Frame: Two months after the start of the study
Mother use of intervention strategies will be measured by transcribing and coding mother behaviors during 12-minute parent-child interactions, using a standard set of toys. The primary dependent variable will be the amount of correct strategy used expressed as a percentage correct. This is the percentage of child communication to which the adult responds correctly (i.e., contingently and within 5 seconds).
Two months after the start of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MacArthur-Bates Communicative Development Inventory (MCDI) (Child)
Time Frame: Two months after the start of the study
Parent report of child's expressive vocabulary and prelinguistic communication skills
Two months after the start of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 6, 2020

Primary Completion (ACTUAL)

September 2, 2021

Study Completion (ACTUAL)

November 24, 2021

Study Registration Dates

First Submitted

August 3, 2020

First Submitted That Met QC Criteria

August 3, 2020

First Posted (ACTUAL)

August 6, 2020

Study Record Updates

Last Update Posted (ACTUAL)

January 10, 2022

Last Update Submitted That Met QC Criteria

January 4, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

N/A at this time

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Responsive training with no video feedback

Subscribe